Méhtestrák: vizsgálatok itt: Kína
86 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleComparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
- Where
- Beijing
- Életkor
- 18 év to 40 év
- People
- 81
- Run by
- Peking University People's Hospital
See details and how to joinNCT07318727 - 2. fázisTaking peopleA Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 30
- Run by
- GlaxoSmithKline
See details and how to joinNCT07108270 - 1/2. fázisTaking peopleStudy of GV20-0251 in Participants With Solid Tumor Malignancies
- Where
- Beijing, Shanghai
- Életkor
- 18 év and over
- People
- 350
- Run by
- GV20 Therapeutics
See details and how to joinNCT07070518 - 1. fázisTaking peopleA Study of GV20-0251 in Advanced or Refractory Solid Tumors
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 10
- Run by
- West China Hospital
See details and how to joinNCT07106827 - 1/2. fázisTaking peopleA Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 38
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05803018 - 2. fázisNot yet taking people in KínaFruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 128
- Run by
- Sun Yat-sen University
See details and how to joinNCT07170982 - No phaseTaking peopleWeight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 240
- Run by
- Peking University People's Hospital
See details and how to joinNCT06169449 - No phaseTaking peopleA Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
- Where
- Guangzhou, Shenzhen
- Életkor
- 18 év and over
- People
- 200
- Run by
- Sun Yat-sen University
See details and how to joinNCT06781151 - No phaseTaking peopleA Cohort Study of Uterine Malignancies
- Where
- Hangzhou
- Életkor
- 20 év to 75 év
- People
- 6200
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05635123 - 2. fázisNot yet taking people in KínaCalcium Channel Blocker Amlodipine for Endometrial Cancer Therapy
- Where
- Beijing
- Életkor
- 18 év to 45 év
- People
- 140
- Run by
- Peking University People's Hospital
See details and how to joinNCT06942377 - No phaseTaking peopleCohort Study of Intrauterine Diseases
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 2000
- Run by
- Wenwen Wang
See details and how to joinNCT07048327 - No phaseNot yet taking people in KínaPatient Journey in Advanced Gynecologic Cancers
- Where
- Chongqing, Guangzhou, Hefei, Wuhan
- Életkor
- 18 év and over
- People
- 780
- Run by
- Tongji Hospital
See details and how to joinNCT07015593 - No phaseTaking peoplePatient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
- Where
- Beijing
- Életkor
- 17 év to 45 év
- People
- 244
- Run by
- Peking University People's Hospital
See details and how to joinNCT05647109 - 2. fázisTaking peopleProgesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
- Where
- Beijing
- Életkor
- 17 év to 45 év
- People
- 38
- Run by
- Peking University People's Hospital
See details and how to joinNCT06102863 - No phaseNot yet taking people in KínaApplication-Assisted Weight Management in Endometrial Cancer Fertility Preservation
- Where
- Beijing
- Életkor
- 18 év to 60 év
- People
- 106
- Run by
- Peking University People's Hospital
See details and how to joinNCT06901778 - No phaseTaking peoplePROfiling Based Endometrial Cancer Adjuvant Therapy
- Where
- Beijing, Changsha, Guangzhou, Hangzhou, Jinan, Ningbo, Shanghai, Wuhan
- Életkor
- 18 év to 75 év
- People
- 590
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05179447 - 1/2. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
- Where
- Baoding, Hangzhou, Harbin, Jinan, Kunming, Lianyungang, Linyi, Luoyang, Shanghai, Shenyang, Taiyuan, Weifang, Xi’an, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 282
- Run by
- Huabo Biopharm Co., Ltd.
See details and how to joinNCT06758557 - 2. fázisNot yet taking people in KínaAdebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
- Where
- Beijing, China
- Életkor
- 18 év and over
- People
- 140
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06771154 - 3. fázisTaking peopleStudy of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
- Where
- Beijing, Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Kunming, Nanning, Shanghai, Taiyuan, Tianjin, Wenzhou, Xi'an, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 412
- Run by
- Hutchmed
See details and how to joinNCT06584032 - 2. fázisNot yet taking people in KínaQL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 26
- Run by
- xiang yang
See details and how to joinNCT06751277 - 1. fázisNot yet taking people in KínaA PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
- Where
- Beijing, Beijjing
- Életkor
- 18 év and over
- People
- 112
- Run by
- Danatlas Pharmaceuticals Co., Ltd
See details and how to joinNCT06614751 - 2. fázisTaking peopleHS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
- Where
- Beijing, Changchun, Changsha, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hanzhou, Harbin, Hefei, Jinan, Kunming, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi’an, Xinjiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 460
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06014190 - 2. fázisNot yet taking people in KínaOral Topotecan With Toripalimab for Patients With Endometrial Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06548763 - 3. fázisNot yet taking people in KínaAnlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
- Where
- Beijing, Binzhou, Changchun, Changsha, Chongqing, Fuzhou, Guangzhou, Guigang, Guilin, Haikou, Hangzhou, Harbin, Hefei, Hohhot, Huizhou, Jiangmen, Jinan, Jining, Kunming, Lanzhou, Linyi, Liuzhou, Luoyang, Meizhou, Nanning, Nanyang, Ningbo, Shanghai, Shaoyang, Shenyang, Taiyuan, Tangshan, Tianjin, Ürümqi, Weifang, Wuhan, Xi'an, Xi’an, Xining, Yantai, Yinchuan, Zaozhuang, Zhengzhou
- Életkor
- 18 év and over
- People
- 420
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06475599 - 1. fázisTaking peopleCLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05410717